Exploring Novel Agents to Target Pathways in Lymphoma

Julie M. Vose, MD, MBA, Chief in the Division of Oncology/Hematology at the University of Nebraska Medical Center, discusses strategies for overcoming resistance in lymphoma during the 2018 Pan Pacific Lymphoma Conference. 

Julie M. Vose, MD, MBA, Chief in the Division of Oncology/Hematology at the University of Nebraska Medical Center, discusses strategies for overcoming resistance in lymphoma during the 2018 Pan Pacific Lymphoma Conference.

While many patients with non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, are able to be cured, there are still many patients that cannot be cured, and the reason is still unclear, Vose explains.